Table 4.
Multivariate analysis of factors influencing OS and PFS in patients with esophageal SCC.
| Endpoint | Variable | Pa | HR | 95% CI |
|---|---|---|---|---|
| OS | Location | 0.063 | 1.254 | 0.988- 1.591 |
| T stage | 0.031 | 1.290 | 1.023- 1.627 | |
| N stage | 0.247 | 1.465 | 0.768- 2.798 | |
| M stage | 0.007 | 1.587 | 1.138- 2.215 | |
| mGPS | < 0.001 | 1.694 | 1.350- 2.126 | |
| PFS | Location | 0.487 | 1.085 | 0.861- 1.368 |
| T stage | 0.049 | 1.252 | 1.001- 1.565 | |
| N stage | 0.310 | 1.377 | 0.743- 2.554 | |
| M stage | < 0.001 | 1.827 | 1.315- 2.538 | |
| mGPS | < 0.001 | 1.555 | 1.243- 1.947 | |
| Platelets | 0.042 | 1.491 | 1.014- 2.193 |
95% CI, 95% confidence interval; HR, hazard ratio; OS, overall survival; PFS, progression-free survival; SCC, squamous cell carcinoma.
a P values were calculated using an adjusted Cox proportional hazards model.